Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
mi
from
Providence, RI
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
USC, Keck School of Medicine
mi
from
Los Angeles, CA
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
USC, Keck School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Texas Health Hospital
mi
from
Arlington, TX
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Texas Health Hospital
mi
from
Arlington, TX
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Instituto de Investigaciones Neurologicas Raul Carrea, FLENI
mi
from
Ciudad Autonoma de Buenos Aire,
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Instituto de Investigaciones Neurologicas Raul Carrea, FLENI
mi
from
Ciudad Autonoma de Buenos Aire,
Click here to add this to my saved trials
Functional Connectivity in Primary Focal Dystonia
Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Functional Connectivity in Primary Focal Dystonia
Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated:  12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated: 12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical Center
mi
from
New York, NY
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering West Harrison
mi
from
Harrison, NY
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering West Harrison
mi
from
Harrison, NY
Click here to add this to my saved trials
Treatment Use of 3,4-Diaminopyridine
Treatment Use of 3,4-Diaminopyridine in Lambert-Eaton Myasthenia and Congenital Myasthenia Gravis
Status: Enrolling
Updated:  12/31/1969
Duke University Hospital
mi
from
Durham, NC
Treatment Use of 3,4-Diaminopyridine
Treatment Use of 3,4-Diaminopyridine in Lambert-Eaton Myasthenia and Congenital Myasthenia Gravis
Status: Enrolling
Updated: 12/31/1969
Duke University Hospital
mi
from
Durham, NC
Click here to add this to my saved trials
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Indiana Unversity
mi
from
Indianapolis, IN
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Indiana Unversity
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Children' Hospital Boston and Massachusetts General Hospital
mi
from
Boston, MA
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Children' Hospital Boston and Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
University of Washington, Health Sciences Building
mi
from
Seattle, WA
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
University of Washington, Health Sciences Building
mi
from
Seattle, WA
Click here to add this to my saved trials
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
University of Washington, Ninth and Jefferson Building
mi
from
Seattle, WA
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
University of Washington, Ninth and Jefferson Building
mi
from
Seattle, WA
Click here to add this to my saved trials
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System, American Lake
mi
from
Tacoma, WA
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System, American Lake
mi
from
Tacoma, WA
Click here to add this to my saved trials
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
Veteran Affairs Puget Sound Health Care System, Seattle
mi
from
Seattle, WA
Structured Treatment of Pain (STOP) Study
Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
Veteran Affairs Puget Sound Health Care System, Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose
Effect of Weight and Insulin Sensitivity on Reproductive Function in Polycystic Ovary Syndrome: Studies in Skeletal Muscle and Adipose Tissue 'PULSE Ancillary Study'
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose
Effect of Weight and Insulin Sensitivity on Reproductive Function in Polycystic Ovary Syndrome: Studies in Skeletal Muscle and Adipose Tissue 'PULSE Ancillary Study'
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated:  12/31/1969
Deaconess Hospital
mi
from
Spokane, WA
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated: 12/31/1969
Deaconess Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated:  12/31/1969
Sacred Heart Medical Center
mi
from
Spokane, WA
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated: 12/31/1969
Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated:  12/31/1969
Holy Family Hospital
mi
from
Spokane, WA
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated: 12/31/1969
Holy Family Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated:  12/31/1969
Valley Hospital
mi
from
Spokane, WA
The Inland Northwest Colon Cancer Survivor's Study
Self Reported Changes in Quality of Life, Demands of Illness, and Sexual Function in Colon Cancer Survivors.
Status: Enrolling
Updated: 12/31/1969
Valley Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Status: Enrolling
Updated:  12/31/1969
NE Neurology
mi
from
Concord, NC
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Status: Enrolling
Updated: 12/31/1969
NE Neurology
mi
from
Concord, NC
Click here to add this to my saved trials
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Status: Enrolling
Updated:  12/31/1969
The Stedman Center on the Duke Center for Living Campus
mi
from
Durham, NC
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Status: Enrolling
Updated: 12/31/1969
The Stedman Center on the Duke Center for Living Campus
mi
from
Durham, NC
Click here to add this to my saved trials
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Status: Enrolling
Updated:  12/31/1969
Raleigh Neurology Associates
mi
from
Raleigh, NC
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Status: Enrolling
Updated: 12/31/1969
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials